| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $2.9B |
| Cost of Revenue | — | — | — | — | — | — | — | $3.9B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.6B | $2.4B | $2.5B | $2.4B | $0.4B | $0.4B | $0.5B | $0.3B |
| Net Income | $2.0B | $1.9B | $1.8B | $1.7B | $0.3B | $0.3B | $0.3B | $0.2B |
| EPS (Basic) | $3.44 | $3.44 | $3.21 | $3.18 | $0.54 | $0.54 | $0.56 | $0.42 |
| EPS (Diluted) | $3.42 | $3.44 | $3.21 | $3.17 | $0.54 | $0.54 | $0.56 | $0.42 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $81.4B | $70.0B | $64.1B | $61.2B | $57.9B | $54.0B | $50.4B | $46.0B |
| Current Assets | $5.0B | $4.3B | $4.1B | $5.1B | $4.2B | $3.3B | $3.1B | $3.1B |
| Cash & Equivalents | — | — | — | — | — | $0.1B | $0.2B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $7.1B | $6.5B | $5.7B | $6.1B | $5.0B | $4.2B | $4.6B | $4.5B |
| Stockholders' Equity | $23.6B | $19.5B | $17.6B | $16.7B | $15.6B | $14.6B | $13.2B | $12.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.1B | $4.6B | $5.3B | $3.9B | $2.2B | $2.8B | $3.3B | $3.1B |
| Investing Cash Flow | $-11.0B | $-7.4B | $-5.9B | $-4.7B | $-4.3B | $-4.7B | $-4.3B | $-4.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $7.0B | $2.8B | $0.6B | $0.7B | $2.1B | $1.8B | $1.2B | $0.9B |